AMH and polycystic ovary syndrome: Metabolomic studies reveal that elevated AMH levels in PCOS patients correlate with reduced noradrenergic metabolite DOPGAL, potentially disrupting sympathetic modulation of follicular responsiveness and associating with steroidogenic pathway dysregulation in ovarian dysfunction (19).